CPA Firm Daszkal Bolton LLP Completes Two-Year Audit of Greyson International, Inc.
Shareholder Conference Call Scheduled for Thursday, July 14, 2011
BOCA RATON, Fla.—June 29, 2011-Greyson International, Inc. (GYSN.PK) announced today that the CPA firm Daszkal Bolton LLP has completed a two-year audit of the Company. Greyson International intends to file the two-year audit with the OTC Pink Sheets.
“We are very pleased that we have completed a major step in our goal of becoming a fully reporting company,” said Greyson International CEO Harvey Tauman. “We plan to move forward with this goal as a top priority.”
A conference call to update shareholders on business developments is scheduled for Thursday, July 14. Further details regarding the call will be announced closer to the call date.
About Greyson International, Inc.
Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonproducts.com, join the Greyson Facebook group page by visiting www.facebook.com and searching “Greyson Products” or follow Greyson on Twitter at www.twitter.com/greysonproducts.
This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.